MEF2C and chronic obstructive pulmonary disease: In addition, molecular mechanisms of diaphragm muscle atrophy in patients with severe COPD have been reported to be downregulated in muscle-specific microRNA expressions and to be higher in histone deacetylase 4 and myocyte enhancer factor 2C protein levels [61].